316 related articles for article (PubMed ID: 27448553)
21. Effects of aminoguanidine and N(omega)-nitro-L-arginine methyl ester on vascular hyporeactivity induced by endotoxaemia.
Ismailoglu UB; Pekiner C; Yorganci K; Sahin-Erdemli I
Eur J Surg; 2001 Nov; 167(11):803-9. PubMed ID: 11848232
[TBL] [Abstract][Full Text] [Related]
22. Hyporesponsiveness to Ca2+ of aortic smooth muscle in endotoxin-treated rats: no-dependent and -independent in vitro mechanisms.
Ho KH; Kwan CY; Bourreau JP
Res Commun Mol Pathol Pharmacol; 1996 Jun; 92(3):275-84. PubMed ID: 8827826
[TBL] [Abstract][Full Text] [Related]
23. Activation of the 5-HT
Seitz BM; Fink GD; Watts SW
Exp Physiol; 2020 Dec; 105(12):2025-2032. PubMed ID: 33052620
[TBL] [Abstract][Full Text] [Related]
24. The influence of chronic inhibition of nitric oxide synthesis on contractile and relaxant properties of rat carotid and mesenteric arteries.
Heijenbrok FJ; Mathy MJ; Pfaffendorf M; van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):504-11. PubMed ID: 11138842
[TBL] [Abstract][Full Text] [Related]
25. Comparative regional haemodynamic effects of the nitric oxide synthase inhibitors, S-methyl-L-thiocitrulline and L-NAME, in conscious rats.
Wakefield ID; March JE; Kemp PA; Valentin JP; Bennett T; Gardiner SM
Br J Pharmacol; 2003 Jul; 139(6):1235-43. PubMed ID: 12871844
[TBL] [Abstract][Full Text] [Related]
26. Effects of S-ethylisothiourea, a potent inhibitor of nitric oxide synthase, alone or in combination with a nitric oxide donor in splanchnic artery occlusion shock.
Squadrito F; Altavilla D; Squadrito G; Campo GM; Ioculano M; Canale P; Rossi F; Saitta A; Caputi AP
Br J Pharmacol; 1996 Sep; 119(1):23-8. PubMed ID: 8872352
[TBL] [Abstract][Full Text] [Related]
27. Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta.
Adeagbo AS; Triggle CR
Br J Pharmacol; 1993 Jun; 109(2):495-501. PubMed ID: 7689395
[TBL] [Abstract][Full Text] [Related]
28. Reduced vascular response to phenylephrine during exposure to lipopolysaccharide in vitro involves nitric oxide and endothelin 1.
Scicluna JK; Mansart A; Ross JJ; Reilly CS; Brown NJ; Brookes ZL
Shock; 2008 Mar; 29(3):417-21. PubMed ID: 18437715
[TBL] [Abstract][Full Text] [Related]
29. Chronic inhibition of nitric-oxide synthase potentiates endothelium-dependent contractions in the rat aorta by augmenting the expression of cyclooxygenase-2.
Qu C; Leung SW; Vanhoutte PM; Man RY
J Pharmacol Exp Ther; 2010 Aug; 334(2):373-80. PubMed ID: 20444882
[TBL] [Abstract][Full Text] [Related]
30. Nitric oxide pathway counteracts enhanced contraction to membrane depolarization in aortic rings of rats on high-sodium diet.
Cordaillat M; Fort A; Virsolvy A; Elghozi JL; Richard S; Jover B
Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1557-62. PubMed ID: 17185406
[TBL] [Abstract][Full Text] [Related]
31. Alpha-vascular responses after short-term and long-term inhibition of nitric oxide synthesis.
Aleixandre A; López-Miranda V; Ortega A
J Cardiovasc Pharmacol; 2001 Feb; 37(2):133-42. PubMed ID: 11209996
[TBL] [Abstract][Full Text] [Related]
32. Exogenous NO inhibits basal NO release from vascular endothelium in vitro and in vivo.
Ma XL; Lopez BL; Christopher TA; Birenbaum DS; Vinten-Johansen J
Am J Physiol; 1996 Nov; 271(5 Pt 2):H2045-51. PubMed ID: 8945924
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects.
Handy RL; Harb HL; Wallace P; Gaffen Z; Whitehead KJ; Moore PK
Br J Pharmacol; 1996 Sep; 119(2):423-31. PubMed ID: 8886430
[TBL] [Abstract][Full Text] [Related]
34. Inducible nitric oxide synthase and vascular reactivity in rat thoracic aorta: effect of aminoguanidine.
Scott JA; Machoun M; McCormack DG
J Appl Physiol (1985); 1996 Jan; 80(1):271-7. PubMed ID: 8847314
[TBL] [Abstract][Full Text] [Related]
35. Nitric oxide synthase-independent release of nitric oxide induced by KCl in the perfused mesenteric bed of the rat.
Mendizabal VE; Poblete I; Lomniczi A; Rettori V; Huidobro-Toro JP; Adler-Graschinsky E
Eur J Pharmacol; 2000 Dec; 409(1):85-91. PubMed ID: 11099704
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
Szabó C; Bryk R; Zingarelli B; Southan GJ; Gahman TC; Bhat V; Salzman AL; Wolff DJ
Br J Pharmacol; 1996 Aug; 118(7):1659-68. PubMed ID: 8842429
[TBL] [Abstract][Full Text] [Related]
37. Regulation of ductus arteriosus patency by nitric oxide in fetal lambs: the role of gestation, oxygen tension, and vasa vasorum.
Clyman RI; Waleh N; Black SM; Riemer RK; Mauray F; Chen YQ
Pediatr Res; 1998 May; 43(5):633-44. PubMed ID: 9585010
[TBL] [Abstract][Full Text] [Related]
38. Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform.
Southan GJ; Zingarelli B; O'Connor M; Salzman AL; Szabó C
Br J Pharmacol; 1996 Feb; 117(4):619-32. PubMed ID: 8646406
[TBL] [Abstract][Full Text] [Related]
39. Comparison between selective and nonselective nitric oxide synthase inhibition and phenylephrine in normal and endotoxic swine.
Cohen RI; Shapir Y; Davis A; Loona R; Scharf SM
Crit Care Med; 2000 Sep; 28(9):3257-67. PubMed ID: 11008990
[TBL] [Abstract][Full Text] [Related]
40. Influence of different classes of NO synthase inhibitors in the pig gastric fundus.
Dick JM; Lefebvre RA
Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):488-94. PubMed ID: 9349636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
